PLANTS, THEIR PROPERTIES, YOUR BALANCE.
Botanical photograph: Gum arabic tree (Acacia senegal (L.) Willd.)

BOTANICAL PHOTOGRAPH · FABACEAE

THE HERBARIUM · FABACEAE

Gum arabic tree

Acacia senegal (L.) Willd.

Source topics

These topics describe what the sources discuss, including unproven claims and risks. They are not therapeutic recommendations.

Documentary entry
  • Pharmacopoeial material: exuded gum (gum arabic)Insufficient evidence
  • Gum arabic: metabolic researchHuman studies — read the findings
Plant partExuded gum (gum arabic)
FormsStudied preparation — documentary reference

Documentary entryReported uses only. No preparation or therapeutic use is recommended.

Research applies to a specific preparation; no self-treatment is recommended.

Identity & origin

BOTANICAL IDENTITY

The right name is the first step.

Shrub or tree in the Fabaceae family. Recorded native range: Tropical and southern Africa to India. The listed pharmacopoeial material is exuded gum (gum arabic). Kew places the inventory name under Senegalia senegal.

Part used
Exuded gum (gum arabic)
Origin & distribution
Tropical and southern Africa to India

Also known as: Senegalia senegal

Check the species, plant part and complete botanical name together. A photograph alone cannot identify a harvest safely for consumption.

An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.

Uses & evidence

UNDERSTANDING THE USES

Properties & uses.

Insufficient evidence

Pharmacopoeial material: exuded gum (gum arabic)

The listed material is exuded gum, not bark or a leaf infusion. Kew accepts the name Senegalia senegal. This notice infers no therapeutic indication.

The references do not establish a benefit. Lack of evidence is not assurance of safety.

Read the source
Human studies — read the findings

Gum arabic: metabolic research

The authors reported changes in fasting glucose, blood pressure and digestive symptoms. Substantial dropout and multiple endpoints; no reduction in cardiovascular events was demonstrated.

A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.

Read the source

The traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.

Precautions before use

BEFORE ANY USE

Precautions & contraindications.

This guidance does not cover every individual situation. Missing information is not a guarantee of safety.

Contraindications & precautions

  • Insufficient dataThis targeted audit does not provide a comprehensive contraindication review; this does not mean contraindications are absent.

Medicine interactions

  • Insufficient dataThis dossier cannot establish compatibility with medication. A limited study does not replace an interaction review of the exact product.
Other retained warnings · review incomplete

These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.

Restrictions and precautions

  • This botanical dossier does not establish medicinal-use safety. Anyone with a medical condition or taking medicine needs professional assessment of the specific product.

Medicine interactions

  • Interactions have not been sufficiently assessed in the sources retained for this notice; an incomplete assessment guarantees no compatibility.

Pregnancy, breastfeeding and children

No medicinal use is offered during pregnancy or breastfeeding; this dossier cannot establish safety in these situations.

No paediatric preparation or dose is offered in this notice.

“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.

Adverse effects

  • This notice does not provide a complete adverse-effect assessment. Historical use alone cannot exclude toxicity.

Pregnancy & breastfeeding

No medicinal use is offered during pregnancy or breastfeeding; this dossier cannot establish safety in these situations.

Children & adolescents

No paediatric preparation or dose is offered in this notice.

If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.

Forms & how they are used

DOCUMENTED FORMS

One plant, several preparations.

Only forms documented in this profile’s sources are presented.

Studied preparation — documentary referenceExuded gum (gum arabic) · Route: not recommended for self-treatment

Oral gum arabic supplement, not bark tea.

Please note: Research description only; no self-treatment dose, recipe or duration is offered.

Read the source
Available evidence

EXPLORE THE EVIDENCE

The available evidence.

This reference concerns a defined preparation of Acacia senegal (L.) Willd.. Findings come from participants studied in a specific setting and do not validate every preparation of the plant.

Human studies — read the findings

Gum arabic: metabolic research

Effects on markers justify neither a weight-loss promise nor replacing treatment.

A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.

Read the reference

Limitations to keep in mind.

Effects on markers justify neither a weight-loss promise nor replacing treatment.

Studies, findings & limitations

THE RESEARCH

What the research shows.

A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.

01Human studies — read the findings

Gum arabic: metabolic research — 2021

A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.

Type of research
Randomised single-blind placebo-controlled trial in adults at metabolic risk.
Preparation concerned
Oral gum arabic supplement, not bark tea.
Observed results
The authors reported changes in fasting glucose, blood pressure and digestive symptoms.
Limitations to consider
Substantial dropout and multiple endpoints; no reduction in cardiovascular events was demonstrated.
Read the reference

What can we take from this?

Substantial dropout and multiple endpoints; no reduction in cardiovascular events was demonstrated. Interactions, pregnancy and long-term use require separate assessment.

Documentary review dated 09/10/2026. The references remain available to check the context.

Sources & last review
Looking for personal guidance?View consultations · from $40 USD
WhatsApp Appointments